For 37 years, Rick Doblin has been pushing the F.D.A. to approve treating post-traumatic stress disorder with MDMA, better known as Ecstasy. He tells Steve why he persisted for so long, why he doesn’t like calling drug use “recreational,” and what he learned from his pet wolf.
Jul 18
31. Peter Leeson on Why Trial-by-Fire Wasn’t Barbaric and Why Pirates Were Democratic
He’s an economist who studies even weirder things than Steve. They discuss whether economics is the best of the social sciences, and why it’s a good idea to get a tattoo of a demand curve on your bicep. This episode originally aired on June 11th, 2021. Hosted by Simplecast, an Ad ... Show More
45m 40s
Jul 11
30. Dambisa Moyo Says Foreign Aid Can’t Solve Problems, but Maybe Corporations Can
The African-born economist has written four bestselling books, including Dead Aid, which Bill Gates described as “promoting evil.” In her new book about corporate boards, Dambisa uses her experience with global corporations to explore how they can better meet society’s demands. A ... Show More
43m 33s
Sep 2021
MDMA for PTSD with Rick Doblin
Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ... Show More
15m 56s
Nov 2020
The future of psychedelic-assisted psychotherapy | Rick Doblin
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this fascinating dive into the science of psychedelics, he explains how drugs like LSD, psilocy ... Show More
14m 50s
Aug 2019
#65 - Rick Doblin, Ph.D.: MDMA— the creation, scheduling, toxicity, therapeutic use, and changing public opinion of what is possibly the single most important synthetic molecule ever created by our species
<p>In this episode, Rick Doblin, founder and executive director of MAPS, discusses MDMA, a molecule that has (at a minimum) revolutionary therapeutic benefits for PTSD, but arguably could have, at the highest order, a lasting impact on humanity's ability to peacefully coexist. Ri ... Show More
3 h